CHE on NYSE
Chemed Corporation
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with Aveanna Healthcare Holdings, Inc., AdaptHealth Corp. or Addus HomeCare Corp, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
Segment Vitas brought in 64% of the revenue Chemed Corporation broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Segment Vitas | $1.3B | $1.5B | $1.6B |
| Segment Roto Rooter | $949.4M | $900.3M | $899.9M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue67¢$1.7B
- Selling, general and admin16¢$417.2M
- Other costs2¢$48.5M
- Interest0¢$1.8M
- Income tax4¢$90.5M
- Profit10¢$265.2M
Out of $2.5B in revenue.4
Where each dollar of operating cash went, fiscal 2025
- Capital spending12¢$62.8M
- Dividends paid6¢$31.7M
- Share buybacks82¢$431.5M
Out of $388.3M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.4
Financial statements
Every line of the income statement in the latest annual report, as filed.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Service revenues and sales (Note 2) | $2.5B | $2.4B | $2.3B |
| Cost of services provided and goods sold (excluding depreciation) | $1.7B | $1.6B | $1.5B |
| Selling, general and administrative expenses | $417.2M | $424.4M | $395.1M |
| Depreciation | $54.6M | $52.9M | $50.8M |
| Amortization | $10.3M | $10.2M | $10.1M |
| Other operating expenses (Note 20) | $2.9M | $446.0K | $2.3M |
| Total costs and expenses | $2.2B | $2.1B | $1.9B |
| Income from operations | $338.2M | $366.5M | $340.6M |
| Interest expense | -$1.8M | -$1.8M | -$3.1M |
| Other income - net (Note 10) | $19.3M | $34.8M | $12.9M |
| Income before income taxes | $355.8M | $399.5M | $350.4M |
| Income taxes (Note 11) | -$90.5M | -$97.5M | -$77.9M |
| Net Income | $265.2M | $302.0M | $272.5M |
| Net Income | $18.42 | $20.10 | $18.11 |
| Average number of shares outstanding | 14.4M shares | 15.0M shares | 15.1M shares |
| Net Income | $18.34 | $19.89 | $17.93 |
| Average number of shares outstanding | 14.5M shares | 15.2M shares | 15.2M shares |
Every line of the balance sheet in the latest annual report, as filed.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents (Note 9) | $74.5M | $178.3M | |
| Accounts receivable | $182.6M | $171.2M | |
| Inventories | $7.5M | $8.2M | |
| Prepaid income taxes | $11.2M | $11.1M | |
| Prepaid expenses | $26.8M | $26.0M | |
| Total current assets | $302.6M | $394.7M | |
| Investments of deferred compensation plans held in trust (Notes 15 and 17) | $140.3M | $131.0M | |
| Properties and equipment, at cost, less accumulated depreciation (Note 13) | $205.7M | $200.8M | |
| Lease right of use asset (Note 14) | $131.2M | $127.3M | |
| Identifiable intangible assets less accumulated amortization (Note 6) | $82.8M | $92.2M | |
| Goodwill | $667.0M | $666.7M | $585.0M |
| Other assets (Note 12) | $8.7M | $55.8M | |
| Total Assets | $1.5B | $1.7B | $1.7B |
| Accounts payable | $64.5M | $44.1M | |
| Accrued insurance | $62.1M | $56.7M | |
| Income taxes (Note 11) | $2.5M | $7.6M | |
| Accrued compensation | $58.3M | $92.1M | |
| Short-term lease liability (Note 14) | $40.9M | $42.3M | |
| Other current liabilities (Note 21) | $58.9M | $42.9M | |
| Total current liabilities | $287.1M | $285.7M | |
| Deferred income taxes (Note 11) | $19.3M | $25.9M | |
| Deferred compensation liabilities (Note 15) | $136.1M | $126.0M | |
| Long-term lease liability (Note 14) | $102.9M | $98.5M | |
| Other liabilities | $13.3M | $13.4M | |
| Total Liabilities | $558.8M | $549.6M | |
| Capital stock - authorized 80,000,000 shares $1 par; issued 37,594,676 shares (2024 - 37,422,348 shares) | $37.6M | $37.4M | |
| Paid-in capital | $1.6B | $1.5B | |
| Retained earnings | $3.0B | $2.7B | |
| Treasury stock - 23,884,187 shares (2024 - 22,865,842 shares), at cost | -$3.6B | -$3.1B | |
| Deferred compensation payable in Company stock (Note 15) | $2.4M | $2.2M | |
| Total Stockholders' Equity | $979.4M | $1.1B | $1.1B |
| Total Liabilities and Stockholders' Equity | $1.5B | $1.7B | |
| Capital stock - authorized | 80.0M shares | 80.0M shares | |
| Capital stock - par value | $1.00 | $1.00 | |
| Capital stock - issued | 37.6M shares | 37.4M shares | |
| Treasury stock | 23.9M shares | 22.9M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income | $265.2M | $302.0M | $272.5M |
| Depreciation and amortization | $64.8M | $63.0M | $60.9M |
| Stock option expense | $32.7M | $32.0M | $30.1M |
| Benefit for deferred income taxes | -$5.9M | -$4.1M | -$8.0M |
| Noncash portion of long-term incentive compensation | $4.9M | $18.8M | $9.3M |
| Litigation settlements | $1.4M | -$5.8M | $2.0M |
| Noncash directors' compensation | $1.1M | $1.3M | $1.4M |
| Amortization of debt issuance costs | $321.0K | $321.0K | $580.0K |
| (Increase)/decrease in accounts receivable | -$11.6M | $10.7M | -$41.5M |
| Decrease/(increase) in inventories | $650.0K | $3.8M | -$1.7M |
| (Increase)/decrease in prepaid expenses | -$844.0K | $4.2M | $87.0K |
| Decrease in accounts payable and other current liabilities | -$5.2M | -$9.3M | -$9.3M |
| Change in current income taxes | -$6.2M | $2.2M | $11.7M |
| Net change in lease assets and liabilities | -$806.0K | -$674.0K | -$1.4M |
| Decrease/(increase) in other assets | $36.8M | -$25.6M | -$10.0M |
| Increase in other liabilities | $10.4M | $22.7M | $12.8M |
| Other sources | $459.0K | $1.8M | $836.0K |
| Net cash provided by operating activities | $388.3M | $417.5M | $330.3M |
| Capital expenditures | -$62.8M | -$49.5M | -$56.9M |
| Proceeds from sale of fixed assets | $4.6M | $3.3M | $640.0K |
| Business combinations, net of cash acquired | -$225.0K | -$97.4M | -$4.0M |
| Other uses | -$888.0K | -$295.0K | -$434.0K |
| Net cash used by investing activities | -$59.3M | -$143.9M | -$60.6M |
| Purchases of treasury stock | -$431.5M | -$361.4M | -$67.7M |
| Dividends paid | -$31.7M | -$27.1M | -$23.5M |
| Proceeds from exercise of stock options | $27.2M | $56.5M | $102.2M |
| Change in cash overdraft payable | $11.0M | -$15.7M | $15.7M |
| Capital stock surrendered to pay taxes on stock-based compensation | -$8.8M | -$9.5M | -$9.6M |
| Payments on other long-term debt | -$97.5M | ||
| Other sources/(uses) | $1.1M | -$2.0M | $490.0K |
| Net cash used by financing activities | -$432.8M | -$359.2M | -$79.8M |
| (Decrease)/increase in cash and cash equivalents | -$103.8M | -$85.6M | $189.8M |
Leadership
Who has led Chemed Corporation, and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
- Chief executive officerJoel L. Wherley Aug 27, 2025 to now14
- Chief executive officerKevin J. McNamara Dec 30, 2003 to Aug 27, 202515
- ChairEdward L. Hutton Sep 3, 2003 to May 20, 200816
- PresidentKevin J. McNamara Dec 30, 2003 to now15
- Chief financial officerMichael D. Witzeman Feb 20, 2024 to now17
- Chief financial officerDavid Patrick Williams Mar 10, 2004 to Nov 15, 202318
Board members and other officers (26)
- vice president and controllerMichael D. Witzeman Apr 7, 2017 to Nov 8, 202319
- Executive Vice PresidentNicholas Michael Westfall Jun 16, 2016 to now20
- vice presidentThomas C. Hutton Jan 6, 2004 to now21
- vice presidentSpencer S. Lee Jan 12, 2004 to now22
- executive vice presidentTimothy S. Otoole Feb 25, 2004 to Jun 16, 201623
- Vice President and ControllerArthur Tucker V. Jr. Dec 24, 2003 to Mar 3, 201724
- Board memberEileen P. McCarthy May 18, 2023 to now25
- Board memberJohn Meredith Mount Jr. Aug 11, 2022 to now26
- Board memberChristopher J. Heaney May 19, 2020 to now27
- Board memberRon Delyons May 19, 2020 to now28
- Board memberThomas P. Rice Jun 2, 2009 to May 21, 202429
- Board memberAndrea R. Lindell May 21, 2008 to now30
- Board memberFrank E. Wood May 16, 2006 to Jan 7, 202031
- Board memberGeorge J. Walsh Iii. Mar 11, 2005 to now32
- Board memberWalter L. Krebs May 17, 2005 to Aug 23, 201933
- Board memberThomas C. Hutton Jan 6, 2004 to now21
- Board memberPatrick P. Grace Jan 30, 2004 to now34
- Board memberDonald E. Saunders Feb 4, 2004 to May 17, 202235
- Board memberSpencer S. Lee Feb 25, 2004 to Feb 25, 200436
- Board memberTimothy S. Otoole Feb 25, 2004 to Feb 19, 201023
- Board memberJoel F. Gemunder Mar 25, 2004 to May 17, 202237
- Board memberDonald Breen May 18, 2004 to May 16, 200638
- Board memberSandra E. Laney Dec 29, 2003 to Oct 20, 200839
- Board memberKevin J. McNamara Dec 30, 2003 to now15
- General counselBrian C. Judkins Sep 2, 2020 to now40
- General counselNaomi C. Dallob May 24, 2017 to May 11, 202041
Former names
- ROTO-ROOTER INCJul 15, 2003 to Jun 16, 20043
Timeline
Recent filings
- Oct 1, 20264
- Sep 30, 20264
- Sep 29, 20264
- Sep 28, 2026144
- Sep 24, 2026144
- Sep 21, 20264
- Aug 24, 20264
- Aug 24, 20264
- Aug 21, 2026144
- Aug 12, 2026SCHEDULE 13G
- Aug 10, 20264
- Aug 6, 20264
- Aug 4, 20264
- Aug 3, 20264
- Aug 3, 2026144
Every filing from the last three years, summarized. The full record is on SEC EDGAR.2
Links
- Websitewww.chemed.com1
- WikidataQ106241500
- SEC EDGARCIK 19584
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataChemed Corporation on Wikidata
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16SEC EDGAREdward L. Hutton, Chair
- 17
- 18
- 19
- 20
- 21SEC EDGARThomas C. Hutton, vice president
- 22SEC EDGARSpencer S. Lee, vice president
- 23
- 24
- 25SEC EDGAREileen P. McCarthy, Board member
- 26
- 27SEC EDGARChristopher J. Heaney, Board member
- 28SEC EDGARRon Delyons, Board member
- 29SEC EDGARThomas P. Rice, Board member
- 30SEC EDGARAndrea R. Lindell, Board member
- 31SEC EDGARFrank E. Wood, Board member
- 32SEC EDGARGeorge J. Walsh Iii., Board member
- 33SEC EDGARWalter L. Krebs, Board member
- 34SEC EDGARPatrick P. Grace, Board member
- 35SEC EDGARDonald E. Saunders, Board member
- 36SEC EDGARSpencer S. Lee, Board member
- 37SEC EDGARJoel F. Gemunder, Board member
- 38SEC EDGARDonald Breen, Board member
- 39SEC EDGARSandra E. Laney, Board member
- 40SEC EDGARBrian C. Judkins, General counsel
- 41SEC EDGARNaomi C. Dallob, General counsel